Literature DB >> 9234665

Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography.

F D Russell1, J N Skepper, A P Davenport.   

Abstract

Endothelin A (ET(A)) and ET(B) receptors located on vascular smooth-muscle cells mediate potent vasoconstriction in animal and human blood vessels. Although vascular endothelial ET(B) receptors mediate vasodilatation through release of nitric oxide, prostacyclin, or an endothelium-derived hyperpolarizing factor in animal vessels, there is less evidence to support ET-mediated endothelium-dependent relaxation in human arteries. We investigated the regional and subcellular localization of ET-receptor subtypes in human epicardial coronary arteries obtained from patients with congestive heart failure undergoing cardiac transplantation. Radioligand-binding studies revealed a predominance of the ET(A)-receptor subtype in the coronary artery. ET(A) and ET(B) receptors were located in the media and in perivascular structures by using macroautoradiography. Specific binding in the intimal layer was low. Autoradiography at the ultrastructural level revealed the presence of ET(A) and ET(B) receptors on medial vascular smooth-muscle cell plasmalemma and plasmalemmal vesicles with a predominance of the ET(A) subtype. ET receptors were not detected in either luminal endothelial cells of the coronary arteries or endothelial cells lining small adventitial blood vessels. This study is the first to identify the subcellular localization of ET receptors in human coronary artery vascular smooth-muscle cells. These receptors probably mediate the well-established vasoconstrictor response to ET-1. The inability to detect ET receptors on endothelial cells suggests a minor role for endothelial cells in ET-mediated vasodilatation of the coronary vasculature.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234665     DOI: 10.1097/00005344-199706000-00017

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  Endothelin receptor expression and pharmacology in human saphenous vein graft.

Authors:  J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 2.  Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure.

Authors:  Navneet S Rehsia; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

Review 3.  Polarized Proteins in Endothelium and Their Contribution to Function.

Authors:  Abigail G Wolpe; Claire A Ruddiman; Phillip J Hall; Brant E Isakson
Journal:  J Vasc Res       Date:  2021-01-27       Impact factor: 1.934

Review 4.  Lead (Pb) Exposure Enhances Expression of Factors Associated with Inflammation.

Authors:  Emilia Metryka; Karina Chibowska; Izabela Gutowska; Anna Falkowska; Patrycja Kupnicka; Katarzyna Barczak; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2018-06-20       Impact factor: 5.923

Review 5.  Therapeutic Effects of Anthocyanins for Vision and Eye Health.

Authors:  Yuri Nomi; Keiko Iwasaki-Kurashige; Hitoshi Matsumoto
Journal:  Molecules       Date:  2019-09-11       Impact factor: 4.411

Review 6.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.